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Introduction
A primary goal in biological research is to understand human de-
velopment, however research on humans in restricted. Although 
isolation of human embryonic stem cells (hESCs) and the gener-
ation of human induced pluripotent stem cells, have led to more 
options in the field of human biology, there is still need to ana-
lyze these cells in an in vivo setting. As a result, many researchers 
are now turning to human animal chimera research (Hermerén, 
2015). The definition of a chimera, suggested by Lensch et al. 
(2007), is an organism containing cells from two or more individ-
uals of the same or different species. Behringer (2007) proposed, 
that a chimera is an organism with two cell lines, where the in-
dividual is “composed of somatic and, in certain cases, germline 
tissues derived from more than one zygote.” 
There are different types of chimeras, Tetragametic chimeras, 
arise in many cases from in vitro fertilization (IVF), a route of 
fertilization, in which an egg and sperm are combined in a lab-
oratory dish, and the resulting embryo is then transferred into 
the uterus. Because the ensuing embryos were grown in close 
contact, Tetragametic chimeras can result (Granzen, R.R, 2014). 
Tetragemetic chimeras also occur when twin zygotes fuse to-
gether and develop into one body. As a result, the individual’s 
tissues are derived from more than one zygote, and contain 
two sets of DNA. There have been cases where this happened, 
and affected the individual later on in life, when she has her 
own child and if a DNA test is done, it might not match up. It 
can be her ‘sisters’ genes that she fused with that matches her 
children’s. Further testing will prove it’s her child by matching 
the same genotype in some parts of her body. A person who has 
two different eye colors, can be from the fusion of two zygotes, 
among other causes. Consequently, someone born with male 
parts and female parts can be male and female early embryos 
that merged together (Norton and Zehner, 2008). But here, 
chimeras spoken about are human animal chimeras, which are 
being studied more by scientists in the hope to discover cures 
for diseases, such as Alzheimer’s and Parkinson’s and to develop 
vaccines, for example to help fight HIV.
Human animal chimeras have been created by “grafting human 
cells and tissues into the embryos, fetuses, or adults of vertebrate 
model organisms (Behringer, 2007).” Currently researchers and 
scientists are experimenting how the use of chimeras can ad-
vance the field of medicine. Scientists are utilizing the unique 
ability of stem cells to proliferate and differentiate into various 
cells. They are using the idea of stem cell research, but with a 
twist. Scientists are injecting human stem cells (hCSs) into ani-
mal embryos for the purpose of studying human diseases. When 
a fetus is forming, the immune system is not mature enough to 
attack anything foreign, therefore modifications can be made 
in an embryo. For example, early discovery of an abnormality 
can be treated with stem cell administration. The injected cells 
can freely proliferate and/or differentiate into new cells, replace 
the diseased ones, and regenerate damaged tissue. Although this 
concept might sound relatively new, the idea of chimeras are al-
ready being practiced today, by using pig heart valves for humans 
and using animals for skin grafts (Cooper, 2012).
The study of biological systems in humans is largely regulated to 
in vitro models that lack the mechanisms and intricacy of living 
organisms. The complexity of a biologic structure can only be 
precisely and realistically replicated by an in vivo system. In vivo 
studies in laboratory animals are routinely used to model human 
biology and disease but they are not human and therefore can-
not fully replicate human functioning. Transplanting human cells 
into animals provides a way to study human systems in vivo (Sun 
et al., 2007). Humanizing an animal, by implanting human blood, 
neurons, germ cells and other tissues into it, results in a chimera. 
Human animal chimeras, containing animal and human cell lines 
have been generated for decades to facilitate human biological 
studies and therapeutic strategies for disease (Behringer, 2007).
This paper reviews studies done using human animal chimeras. 
Although research with chimeras shows great potential for in-
sight into diseases and medicine, it also raises unique ethical 
issues that must be considered. Are the benefits of using human 
animal chimeras for therapeutic protocols worth the possible 
risks?
Materials and Methods
In order to answer the question proposed above, many re-
search papers and journal articles with relation to this area 
have been read. Touro College’s library data base (tourolib.org) 
was utilized to search for relevant studies and reviews, with 
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databases such as ProQuest, and EBSCO. Further research was 
done by looking up references cited from review articles to find 
original papers. All research accumulated was used in an attempt 
to determine if the benefits of humanized animals outweigh the 
possible risks.
Discussion
There have been a number of studies using human animal chime-
ric mice as an in vivo system to study how stem cells proliferate, 
to test diseases, and to study in more detail the biologic systems. 
Often mice are used, however fetal sheep and fetal goat, during 
the pre-immune stage of development, have also been used as a 
surrogate animal model for human stem cells.  The pre-immune 
stage allows for the transplant of human stem cells, and the 
resulting human animal chimera serves as a unique and clinically 
relevant xenograft animal model for assessing the differentiation 
potential of hSCs in vivo. However from a scientific perspective, 
large animals are not a suitable model for mechanistic research 
and the experiments reviewed here utilize mice, as a host for 
human cells. Small animal models, such as mice and rats accord-
ing to scientists are ideal models to use. The advantages of using 
small animals is that they contain naturally occurring migration 
patterns of stem cells, and provide the availability of extending 
homing and engraftment sites. Additionally, the presence of tis-
sue and organ specific signals from niche, greatly facilitate the 
widespread distribution of human donor cells. It is these rea-
sons that compelled scientists to develop an influential small 
animal model, also known as a humanized animal for pursuing 
hSC basic research (Sun et al., 2007).
Stem Cells
In one study, a human/rat xenograft animal model was gener-
ated by transplanting human low-density mononuclear cells 
(hMNC’s) from human umbilical cord blood (hUCB) into fetal 
rats to study how the human donor stem cells behave in vivo. 
Numerous methods including flow cytometry, Polymerase 
Chain Reaction (PCR), and immunohistochemistry (IHC) 
assay were used to test the human donor contribution. Flow 
cytometry detected that out of 29 recipients, 19 had human 
leukocyte common antigen, CD45+ cells in peripheral blood 
(PB). PCR analysis on 11 different adult tissues showed that 14 
out of 19 CD45+ animals possessed donor derived human en-
graftment in multiple tissues for example, the liver, spleen and 
thymus. The differentiation of human donor cells in the liver 
was assessed by IHC with the use of human specific antibody 
against the hepatocyte marker; CK18. The recipient liver, and 
the human liver had cells that expressed human CK18, while 
normal control rats did not.  IHC examination revealed that 
in the chimeric adult spleen of recipients, many donor derived 
human cell populations expressed CD45 marker indicating the 
human spleen- specific differentiation of donor derived human 
cells. Differentiation of hMNC’s was evaluated in the rat thy-
mus using IHC with a human specific antibody against CD45. 
At 3 weeks, 2 months and 6 months after in utero transplan-
tation, multiple human cells recognized in the recipient thymus 
strongly expressed CD45. Human umbilical cord derived cells 
expressing CK18  underwent site specific differentiation into 
CK18+ human cells in the recipient liver and CD45+ human 
cells in the recipient spleen, which demonstrates that after in 
utero transplantation of hMNC’s, they successfully engraft into 
the liver and spleen of recipients. “Subsequently, the long term 
that survive in these organs are then actively influenced by niche 
signals to contribute in organogenesis (for example liver and 
spleen) recipients in the xenogeneic competitive settings.” This 
experiment concluded that a human rat chimera was successful-
ly developed in which xenogeneic human cells exist for up to 6 
months. This provides a great in vivo model to study how stem 
cells work (Sun et al, 2007).
In another study, hESCs were implanted into the brain ventricles 
of embryonic mice, and found to differentiate into functional 
neural lineages, generating mature active human neurons that 
successfully integrate into the adult mouse forebrain. This study 
reveals insights to recognition of common signals for neural 
differentiation throughout mammalian evolution. The results 
showed that hESCs, when transplanted into the ventricle of the 
developing mammalian brain, can give rise to neuronal and glial 
lineages, suggesting that they are “responsive to environmental 
cues that regulate cell fate determination and differential migra-
tion.” This human animal chimera model provides an in vivo ap-
proach to study human neural development. An approach which 
can be used to study human neurodegenerative and psychiatric 
diseases, and a prospective technique to speed up the screening 
process for therapeutic drugs in the future (Muotri et al., 2005).
Disease Model
In another experiment, an animal with a humanized immune 
system was used to serve as a human disease model for Human 
Immunodeficiency Virus type 1 infection (HIV-1). Rag2−/−vc−/− 
mice, when neonatally injected with human CD34+, develop a 
functional human immune system, with human hematopoiet-
ic cells found in the thymuses, PB, spleen, and bone marrow 
(BM) of the animals. Rag2−/−v c−/− mice become infected with 
HIV-1 when injected with CCR5 tropic HIV-1. HIV-1 infection 
is characterized by constant virus replication and a gradual loss 
of CD4+ T cells and T-cell function. After being injected with 
CCR5 tropic HIV-1, there was a productive infection of human 
cells in PB, thymus, spleen tissue, and BM, and ratios of CD4 (+) 
T cells to CD8 (+) T cells declined. Infection of the mice with 
5000 TCID50 of R5 HIV-1 resulted in a productive infection 
in 3/3 animals. HIV replication was detected in PB, thymuses 
and spleen and BM was also positive for HIV-1. When a 10 fold 
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smaller amount 500 TCID50 was used for infection, only 2/5 
were found to be productively infected with HIV 1 in PB and 
all lymphoid organs. This study demonstrated that HIV-1 can be 
detected in multiple lymphoid tissues of Rag2−/−vc−/− mice, 
using low doses of CCR5- tropic HIV-1. This mouse, consisting 
of a human hematopoietic system, can serve as a small animal 
model for investigating HIV-1 pathogenesis and testing potential 
HIV-1 therapies (An et al., 2007).
In the next study, a chimeric mouse, that sufficiently mimics the 
pathophysiological micro-environment in human liver, was es-
tablished as a unique experimental model to study human liver 
cancer metastasis (Fujiwara et al., 2012). This was discovered 
by expression of an albumin-urokinase plasminogen activator 
(Alb-uPA) transgene in the mouse that is hepatotoxic, resulting 
in the progressive destruction of the mouse liver. It was found 
that when primary healthy normal human hepatocytes were 
transplanted into this mouse, the human hepatocytes were ca-
pable of reconstituting the host liver, highlighting the generous 
capacity of hepatocytes to regenerate. This liver reconstitution 
mouse model has led to a mouse with a humanized liver, by the 
development of mice with livers that are reconstituted by en-
grafted human hepatocytes. This model can be useful for in vivo 
testing of anti-cancer drugs and for studying the mechanisms of 
human cancers (Behringer, 2007). Based on this, scientists theo-
rized that the chimeric mouse can be used as an animal model 
to investigate the underlying mechanisms of tumor metastasis 
into the liver, where the “parenchyma is composed largely of 
normal and healthy human hepatocytes (Fujiwara et al., 2012).”
Human Organs
Human animal chimeras can be used to create complete human 
organs by growing organs made exclusively from human cells in 
a chimeric animal, such as a pig, that could potentially be used 
for organ transplants (Hermerén, 2015).  It was shown, that 
when a mouse that is deficient in T and B cells was injected with 
mouse embryonic stem cells, the T and B cells generated were 
the donor derived mouse embyonic stem cells.  The donor stem 
cells compensated for the lack of T cells by producing T cells. It 
was hypothesized that the same may be true for organs. That if 
an animal that is deficient in an organ is injected with stem cells, 
the stem cells might compensate for what its lacking and grow 
into that organ. 
A study was done where mouse wild-type pluripotent stem 
cells (PSCs) were injected into Pdx1−/− mouse blastocysts, 
(pancreatogenesis-disabled) and found that they developmen-
tally compensated vacancy of the pancreatic “developmental 
niche,” generating almost entirely PSC-derived pancreas. The 
organ generation system described may be useful to treat 
organ failure in humans if pigs or other large animals are used. 
However, several concerns have to be addressed first to bring 
this idea into practice. For example, if interspecific chimeras be-
tween mouse and rat were to be generated, their “embryonic 
lethality is high and maturation into adulthood is uncommon 
(Kobayashi et al., 2010).”
In another study the immune-deficient athymic nude mouse was 
used as a recipient of human tissue grafts, to generate human 
animal chimeras. Because this mouse lacks T cells, it allows for 
many types of xenograft tissues to survive and grow (Behringer, 
2007). Four to seven grafting experiments using human fetal 
material in the nude mouse have been successful. In 1969 the 
first successful transplantation of human malignant tumor tissue 
in the nude mouse was reported. Since then, the number of tu-
mors transplanted has increased steadily. The nude mouse with 
transplanted malignant tumors is a new alternative model in 
oncologic research. It can be applicable to: “basic studies of the 
genesis of cancer tissue, immunology, and cell kinetic research 
(Spang-Thomsen and Visfeldt, 1976).” The nude mouse was used 
as a model for cancer, by grafting pieces of human tumors under 
the skin of the nude mice, in that way, providing a “bio incu-
bator” for tumor growth. This bio incubator gives scientists a 
glimpse into how to treat diseases in humans. The introduction 
of the nude mouse significantly enabled these types of studies 
and this in vivo assay is one of the fundamental experimental 
models for cancer research (Behringer, 2007).
Other experiments include studying mice with human germ 
lines. By subcutaneously transplanting human pre-pubertal and 
adult testicular tissue fragments into immune deficient mice, it is 
seen that human spermatogonia can survive in mice. Hopefully 
with more research, it may be possible to come up with a strat-
egy to preserve the germline of young boys undergoing chemo-
therapies and radiotherapies that cause sterilization (Behringer, 
2007). This study utilized Nude mice and severe combined im-
munodeficiency- non-obese diabetic mice, (SCID-NOD), two 
immunodeficiency recipients to compare the grafting of pre-pu-
bertal and adult murine and adult human testicular tissue. The 
survival of pre-pubertal and adult murine testicular tissues, and 
of adult human testicular tissue was evaluated after subcutane-
ous grafting to immune deficient mice. This xenograft model in 
an immune deficient mouse with pre-pubertal human testicular 
tissue is a theoretical strategy for restoring fertility in childhood 
cancer patients, while circumventing the risk of malignant recur-
rence (Geens et al., 2006).
Ethical issues
These different types of human animal chimeras have provid-
ed important insights into fundamental biological mechanisms 
and the development of therapeutic protocols for human dis-
ease. Chimeras have compensated as human animal models for 
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the study of human processes in vivo. However there has been 
a lot of ethical debate concerning this research. These exper-
iments reviewed have been approved, because the carefully 
transplanted human cells aren’t large enough to make the ani-
mal human. They only humanize certain parts, and the resulting 
chimeras are euthanized after a number of days. Many bound-
aries had to be set with this type of research. In these studies, 
the human donor contribution is very low compared to the 
animal host. Although cells express an evidently higher degree 
of activity than genes, they also are intricately dependent on 
their surroundings. When hSCs are transplanted into animals, 
although they are free to proliferate and differentiate they are 
still in an animal body, and are reliant on their environments. 
They help to humanize an immune system if the animal is 
lacking one, however the host still remains an animal, with a 
distinct cell line of human cells, resulting in a chimera. Only 
in a receptive host, local niches regulate key developmental 
changes for several adult stem cell types, termed as an “insep-
arable relationship”, besides for bone marrow transplantation, 
in which the hematopoietic stem cell is an “agent” in blood 
reconstitution (Hyun, et al 2007). 
Research with human animal chimeras become a problem 
when cognitive capacities of the animal is changed, and when 
the germ line is affected. Therefore, boundaries have been put 
into place. Precautions in this field of research include, using 
progenitors rather than PSCs to avoid germ line contribution, 
which pose the risk of producing human embryos in animals. 
And treating the humanized mice, as a modified crop, by keep-
ing it isolated to prevent it from mating with other mice, as 
well as euthanizing it immediately when research is concluded 
(Hermerén, 2015).
Conclusion
The above studies reviewed involved reconstituting animal 
models by transplanting human stem cells, HIV, cancer, and 
growing human organs in mice. The experiments resulted in a 
human animal chimera, an animal with two cell lines. Human an-
imal chimeras, animals carrying human tissues were used as an 
alternative model to investigate human specific biological pro-
cesses without experimentation on human individuals. Although 
human animal chimeras provide numerous possibilities, there 
is still a lot of controversy and risk associated with it. Since 
research is developing rapidly, and people’s values and percep-
tion of risk and benefit change, not all issues can be settled. 
This approach to studying human pathways in animals concerns 
many people, however with the proper care and thought-out 
methods, research should be able to proceed without extreme 
regulation, and more experiments using human animal chimeras 
for therapeutic protocols should be approved.
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